- UroToday Home
- Recent Abstracts
- Urologic Oncology
- Bladder Cancer
Conferences
SUO 2017: Clinical Utility of Next Generation Sequencing in Urothelial Bladder Cancer
November 30, 2017
SUO 2017: Bladder Cancer: Comparative Analysis of National Cancer Database with Propensity Score Weighting
November 30, 2017
SUO 2017: Cost-effectiveness Analysis Of A Biomarker-based Approach To Select Patients With Muscle-invasive Bladder Cancer For Neoadjuvant Chemotherapy
November 30, 2017
SUO 2017: Effect of Blue-Light Cystoscopy of Recurrence/Progression Rates for Vesigenurtacel-L (Hs-410) with BCG in Patients with NMIBC
November 30, 2017
SUO 2017: Assessment of Blue Light Flexible Cystoscopy with Cysview on Patient Reported Outcomes
November 30, 2017
SUO 2017: Prostate Cancer Anxiety in Men Undergoing Active Surveillance
November 30, 2017
SUO 2017: Prognostic Significance of EZH2 Expression in Upper Tract Urothelial Carcinoma
November 30, 2017
SUO 2017: Impact of Post-Treatment Psychiatric Illness on Survival Outcomes Following Muscle-Invasive Bladder Cancer Patients
November 30, 2017
SUO 2017: Can Free PSA Be Used As A Biomarker in Biochemical Recurrence To Predict Castrate Resistant Prostate Cancer?
November 30, 2017
SUO 2017: Natural History of Indeterminate Pulmonary Nodules in Radical Cystectomy Patients
November 30, 2017
SUO 2017: Discriminative Ability of Commonly Used Indices to Predict Adverse Outcomes After Radical Cystectomy
November 30, 2017
SUO 2017: Novel 3D Organoid Culture Reveals Involvement of Wnt/Beta-Catenin Pathway in Proliferation of Bladder Cancer Cells
November 30, 2017
SUO 2017: Long Term Outcomes - Cystic Clear Renal Cell Carcinoma
November 30, 2017
SUO 2017: Cost-Consequence Analysis of Blue Light Cystoscopy with Hexaminolevulinate in Non-Muscle Invasive Bladder Cancer
November 30, 2017
SUO 2017: Trimodal Therapy Versus Extirpative Surgery for Bladder Cancer, Who May Benefit
November 30, 2017
SUO 2017: Long-term Active Surveillance of Cystic Renal Masses
November 30, 2017